Wednesday November 25 2009 | Biotechnology feed | All feeds

Stimuvax Phase 1/2 survival data support prior results

Monday 2nd of June 2008 8:00

BioPortfolio no longer holds the full text of this article, it is however likley to be available via the below links:

Oncothyreon Inc. (ONTY.O) Key Developments | Stocks | Reuters.com 18 Dec 2008 ... Oncothyreon Inc.'s Stimuvax Phase 1/2 Survival Data Support Prior Results Monday , 2 Jun 2008 08:00am EDT. Oncothyreon Inc. announced the two ...
http://www.reuters.com/finance/stocks/keyDevelopments?symbol...
Press Releases for ONTY Stimuvax Phase 1/2 survival data support prior results · Oncothyreon to receive milestone payment - Jun 2 2008 12:51AM ...
http://www.istockanalyst.com/press/ONTY...
Drugs.com - Clinical Trial Results Archive June 2008 June 2, Stimuvax Phase 1/2 Survival Data Support Prior Results. June 2, New Publication of Phase 2 Data Shows Maribavir Markedly Reduced the Rate of ...
http://www.drugs.com/clinical_trials_archive/June-2008.html...
Archive News & Video for Monday, 02 Jun, 2008 | Reuters.com Stimuvax Phase 1/2 survival data support prior results 08:01 AM EDT. Driven By The Use of Premium-Priced Branded Agents, The HIV Drug Market Will Experience
...
http://www.reuters.com/resources/archive/us/20080602.html...

Browse other news from this organisation: Oncothyreon Inc.

(If any, Generated Automatically)

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.